Azitra, Inc.
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
AZTR | US
Overview
Corporate Details
- ISIN(s):
- US05479L2034
- LEI:
- Country:
- United States of America
- Address:
- 21 BUSINESS PARK DRIVE, SUITE 6, 6405 BRANFORD
- Website:
- https://azitrainc.com/
- Sector:
- Manufacturing
Description
Azitra, Inc. is a clinical-stage biopharmaceutical company focused on precision dermatology. The company leverages its expertise in the skin microbiome, genetic engineering, and proteomics to develop novel treatments for skin diseases. Its therapeutic approach involves creating engineered proteins and live biotherapeutic products (LBPs). The product pipeline includes ATR-12, an engineered microbe (S. epidermidis) for Netherton syndrome; ATR-04 for EGFR inhibitor-associated rash; and ATR-01, a protein candidate for ichthyosis vulgaris.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Azitra, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Azitra, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Azitra, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
